Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice

Author： Simon V.M. Parra A. Minarro J. Arenas M.C. Vinader-Caerols C. Aguilar M.A.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.10, Iss.3, 2000-05, pp. : 159-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the effects of clozapine, haloperidol, chlorpromazine and-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat

By Mobini S. Chiang T.-J. Ho M.-Y. Bradshaw C. M. Szabadi E.

Psychopharmacology, Vol. 152, Iss. 1, 2000-09 ,pp. : 47-54

Springer Publishing Company

Access to resources Recommend Favorite

Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat

By Obuchowicz E. Turchan J.

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 51-59

Elsevier

Access to resources Recommend Favorite

Sigma ligand S14905 and locomotor activity in mice

By Hascoet M. Bourin M. Payeur R. Lombet A. Peglion J.-L.

European Neuropsychopharmacology, Vol. 5, Iss. 4, 1995-12 ,pp. : 481-489

Elsevier

Access to resources Recommend Favorite

Clozapine pre-treatment enhances raclopride catalepsy

By Wadenberg M.-L. Seeman P.

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

The comparative effects of haloperidol, (-)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity

By Ozaki T. Katsumoto E. Yokotani N. Yamagami S.

European Neuropsychopharmacology, Vol. 7, Iss. 3, 1997-08 ,pp. : 181-187

Elsevier

Access to resources Recommend Favorite